What is HemoSonics?
HemoSonics is dedicated to developing clinical tools that provide actionable insights in critical care settings, aiming to enhance patient outcomes and optimize medical cost-efficiency. Its flagship product, the Quantra® Hemostasis Analyzer, offers unique coagulation information for rapid interpretation and streamlined point-of-care bleeding management. Headquartered in Charlottesville, VA, with R&D and manufacturing in Durham, NC, HemoSonics is part of the Stago group, a prominent entity in the in vitro diagnostics sector with a focus on thrombosis and hemostasis. The company's strategic positioning within the medical device industry, particularly in critical care diagnostics, highlights its commitment to innovation and patient well-being.
How much funding has HemoSonics raised?
HemoSonics has raised a total of $25.9M across 6 funding rounds:
Unspecified
$1M
Unspecified
$1.3M
Private Equity
$3.7M
Private Equity
$4M
Private Equity
$15M
Debt
$1M
Unspecified (2008): $1M, investors not publicly disclosed
Unspecified (2013): $1.3M, investors not publicly disclosed
Private Equity (2014): $3.7M, investors not publicly disclosed
Private Equity (2015): $4M, investors not publicly disclosed
Private Equity (2017): $15M, investors not publicly disclosed
Debt (2020): $1M with participation from PPP
What's next for HemoSonics?
The recent major strategic investment signifies a crucial phase for HemoSonics, likely indicating a move towards scaling operations, expanding market reach, and further product development. This enterprise-level capital infusion suggests confidence from investors in HemoSonics' technology and its potential to disrupt the critical care diagnostics market. Future strategic initiatives may involve enhancing the Quantra® system's capabilities, forging new partnerships within the healthcare ecosystem, and potentially exploring new applications for its hemostasis analysis technology. The company's trajectory points towards solidifying its position as a leader in point-of-care diagnostics.
See full HemoSonics company page
